voriconazole has been researched along with Pulmonary Aspergillosis in 136 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (8.09) | 29.6817 |
2010's | 85 (62.50) | 24.3611 |
2020's | 40 (29.41) | 2.80 |
Authors | Studies |
---|---|
Chen, CH; Liu, H; Tang, XL; Zhang, XY; Zhao, SY; Zhou, CJ | 1 |
Chen, X; Liang, S; Xu, J; Zhang, L; Zhou, Y | 1 |
Li, D; Liu, Z; Qiao, L; Yi, L; Yu, L | 1 |
Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE | 1 |
Bhalla, AS; Doddamani, S; Guleria, R; Hadda, V; Khan, MA; Madan, K; Mittal, S; Mohan, A; Tiwari, P | 1 |
Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M | 1 |
Aliakbarian, M; Khaleghi, E; Khodashahi, M; Khodashahi, R; Moghaddam, MD; Naderi, HR; Pasand, MM; Rezayat, KA | 1 |
Hirasawa, Y; Matsui, H; Miyakawa-Tanaka, K; Nakamura, S; Narumoto, O; Suzuki, J; Takeda, K | 1 |
Chiappini, E; Galli, L; Motisi, MA; Pellegrino, R; Taccetti, G; Terlizzi, V | 1 |
Fujita, H; Imataki, O; Ishida, T; Kadowaki, N; Kida, JI; Uemura, M | 1 |
Cheng, D; Han, Q; Wang, K; Wu, H; Xiong, X; Zhuo, K | 1 |
Abtahian, Z; Jamzivar, F; Marjani, M; Moniri, A; Nasiri, N; Poorabdollah, M; Razzaghi-Abyaneh, M; Salehi, M; Salehi, Z; Shams-Ghahfarokhi, M; Sharifynia, S; Tabarsi, P | 1 |
Bellomo, R; Costa-Pinto, R; Finlay, L; Klink, S; Perera, P; Rotherham, H; Trubiano, J; Urbancic, K; Vaz, K | 1 |
Salzer, HJF | 1 |
Chastain, DB; Henao-Martínez, AF; Thompson, GR | 1 |
Dai, X; Gao, C; Jiang, Y; Liu, Q; Liu, X; Shen, L; Sheng, J; Wang, B; Xu, F; Yao, L | 1 |
Akata, K; Fukuda, K; Fukuda, Y; Ikegami, H; Ikushima, I; Kawanami, T; Nakamura, M; Noguchi, S; Yamasaki, K; Yatera, K | 1 |
Abu Sitta, E; Elsaghir, H; Hollingshead, C; Luttmann, K | 1 |
Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A | 1 |
Bongomin, F; Denning, DW; Garcez, T | 1 |
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
Denning, DW; Harris, C; Hashad, R; Kosmidis, C; Lynch, F; Mackenzie, A | 1 |
Ananthamurthy, A; Balasundaram, S; Devaraj, U; Krishnaswamy, UM; Ramachandran, P; Savio, J; Venkatnarayan, K | 1 |
d'Odémont, JP; Ocak, S | 1 |
Baluku, JB; Bongomin, F; Kazibwe, A; Olum, R; Russell, L | 1 |
Aggarwal, R; Arul, A; Chaudhary, H; Dey, P; Mukhopadhyay, K; Rawat, A; Ray, S; Vignesh, P | 1 |
Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP | 1 |
Burrow, AJ; Dennison, SR; Gorki, V; Katare, OP; Kaur, R; Kaushik, A; Rudramurthy, SM; Singh, B; Singh, KK; Swami, R | 1 |
Choi, E; Kim, JH; Kim, SB; Yoon, YK | 1 |
Antinori, S; Bartoletti, M; Cornely, OA; de la Villa, S; Dupont, D; Falces-Romero, I; Ferreira-Paim, K; Gangneux, JP; Garcia-Vidal, C; Giacobbe, DR; Hanses, F; Hoyo, I; Koehler, P; Machado, M; Malaj, X; Meis, JF; Rodríguez-Guardado, A; Sal, E; Salmanton-García, J; Schroeder, M; Seidel, D; Sprute, R; Stemler, J; Valerio, M | 1 |
Hamada, N; Horiuchi, T; Ishiga, M; Itano, J; Kimura, G; Ooue, Y; Suwaki, T; Tanaka, H; Tanaka, S; Tanimoto, Y; Yuzurio, S | 1 |
Abe, K; Abe, Y; Hasegawa, Y; Hishida, T; Kitagawa, Y; Kitago, M; Obara, H; Shinoda, M; Uno, S; Yagi, H | 1 |
Bacle, A; Boglione-Kerrien, C; Gangneux, JP; Le Daré, B; Reizine, F | 1 |
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
Ashizawa, N; Hirayama, T; Imamura, Y; Ito, Y; Izumikawa, K; Koga, S; Miyazaki, T; Mukae, H; Nakano, Y; Saijo, T; Takazono, T; Tashiro, M; Yamamoto, K; Yanagihara, K | 1 |
Bakir Ekinci, P; Demirkan, K; Er, AG; Inkaya, AC; Kara, E; Uzun, O | 1 |
Chong, W; Saha, BK | 1 |
Ladak, K; Rubin, L | 1 |
Alffenaar, JWC; Brüggemann, RJM; Dekkers, BGJ; Groeneveld, GH; Henriet, SSV; Lashof, AMLO; Muilwijk, EW; Russel, FGM; van de Veerdonk, F; van der Hoeven, J; Verweij, PE; Witjes, B | 1 |
Harris, C; Morales, MK; Shoham, S | 1 |
Lu, G; Shen, Y; Yang, Q; Yao, Y; Yu, Y; Zhou, H; Zhou, J | 1 |
Hashizume, H; Kageyama, R; Kaneko, Y | 1 |
Agard, E; Chehab, HE; Dot, C; Dot, JM; Douma, I; Mounier, A; Vie, AL | 1 |
Chi, YM; Di, QG; Du, JF; Jiang, MM; Li, M; Lv, J; Mai, ZT; Shi, J; Song, Z; Sun, BH | 1 |
Bongomin, F; Denning, DW; Harris, C; Hayes, G; Kosmidis, C | 1 |
Ganaie, MB; Mahmood, A; Piracha, S; Qayyum, N | 1 |
Agarwal, R; Bishnoi, A; Handa, S; Sehgal, IS | 1 |
Kasai, H; Nakajima, T; Tanabe, N; Tatsumi, K; Uehara, Y; Yoshino, I | 1 |
Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL | 1 |
Ameur, SB; Bahloul, M; Bouaziz, M; Chabchoub, I; Hachicha, M; Kamoun, T; Kolsi, R; Maaloul, I | 1 |
Chen, TW; Chiu, YC; Fan, HL; Ho, MH; Hsieh, CB | 1 |
Gohar Ali, M; Qamar, FN; Zubairi, ABS | 1 |
Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R | 1 |
Aoshima, M; Hashizume, H; Ito, T; Masuda, Y; Miyazawa, H; Shimauchi, T; Tokura, Y | 1 |
Ando, T; Fujiuchi, S; Hayashi, Y; Ichihara, K; Imamura, Y; Izumikawa, K; Kakeya, H; Kishi, K; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Ogawa, K; Saijo, T; Takazono, T; Tashiro, M; Tokimatsu, I; Yamamoto, K; Yanagihara, K | 1 |
Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P | 1 |
Cao, B; Liu, ZB; Wan, J; Xie, WM; Zhai, ZG | 1 |
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H | 1 |
Campoli, C; Capone, A; Chiappetta, D; Chinello, P; Di Bella, S; Petrosillo, N | 1 |
El-Sherief, A; Gordon, S; Olbrych, T; Tedja, R | 1 |
Fox, DA; Gladue, HS | 1 |
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M | 1 |
Bucknor, MD; Gross, AJ; Link, TM | 1 |
Fujii, T; Hirota, K; Inagaki, N; Yasoda, A | 1 |
Feng, XW; Qu, WX; Zhao, L | 1 |
Chan, T; Ding, WY; McWilliams, R; Yadavilli, RK | 1 |
Barutcu, E; Celik, AD; Pamuk, GE; Pamuk, ON | 1 |
Brown, EV; Davoodi, P; Perry, JR; Wright, SA | 1 |
Audagnotto, S; Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; De Rosa, FG; Di Perri, G; Pagani, N; Simiele, M | 1 |
Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y | 1 |
Braggio, P; Cascio, GL; Cazzadori, A; Concia, E; Conti, M; Cucchetto, G | 1 |
Cheng, Y; Mu, X; Nie, L; Wang, G; Yu, J | 1 |
Akinlolu, Y; Chaparro, C; Howard, SJ; Husain, S; Keshavjee, S; Luong, ML; Mazzulli, T; Richardson, S; Rotstein, C; Shalhoub, S; Singer, LG | 1 |
Kuribayashi, F; Ochi, N; Takigawa, N; Yamagishi, T; Yamane, H | 1 |
Dabó, H; Gomes, I; Marinho, A | 1 |
Cunningham, L; Gallagher, C; Keating, C; Lally, A; McKone, E; Moran, M | 1 |
Betancourt, BY; Boma, N; Garofoli, AC; Sandhu, JS; Sy, AM | 1 |
Mahfoudhi, M; Turki, S | 1 |
Lopez, JL; Tayek, JA | 1 |
Yaguchi, T | 1 |
Burgess, M; Lataifeh, AR; Meena, N | 1 |
Shao, J; Xu, J; Zheng, X | 1 |
Li, L; Ning, H; Shao, HX; Wang, CZ; Wang, YM; Wu, Q; Xing, ZH | 1 |
Izumikawa, K; Tashiro, M | 1 |
Bhalla, AS; Guleria, R; Hadda, V; Khandelwal, R; Khilnani, GC; Madan, K; Mohan, A; Poulose, R; Tiwari, P | 1 |
Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T | 1 |
Ishida, T; Izumi, S; Kamei, K; Kuwata, H; Sakurai, A; Yanai, H | 1 |
Iseman, MD; Peloquin, CA; Schwiesow, JN | 1 |
Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K | 1 |
Baba, T; Endo, T; Enomoto, T; Hagiwara, E; Kato, T; Komatsu, S; Matsushima, A; Nishihira, R; Ogura, T; Sekine, A; Shiihara, J; Shinohara, T; Sogo, Y; Tagawa, A; Takahashi, H; Tsuchiya, N | 1 |
Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ | 1 |
Han, FC; Jureen, R; Tew, CW; Tey, BH | 1 |
Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY | 1 |
Alffenaar, JW; Daenen, SM; Kosterink, JG; Uges, DR; van der Elst, KC | 1 |
Altman, R; Belperio, JA; Eshaghian, P; Gregson, A; Kubak, B; Lynch, JP; Ross, DJ; Saggar, R; Wang, T; Wang, TF; Weigt, SS | 1 |
Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H | 1 |
Duval, A; Hickman, G; Petit, A; Picard, C | 1 |
Wingard, J | 1 |
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
Chudgar, SM; Norton, BL; Person, AK; Stout, JE; Tong, BC | 1 |
Segal, BH; Sherif, R | 1 |
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T | 1 |
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y | 1 |
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS | 1 |
Meersseman, W | 1 |
Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E | 1 |
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N | 1 |
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH | 1 |
Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF | 1 |
Ayub, A; Kenney, CV; McKiernan, FE | 1 |
Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C | 1 |
Kuithan, F; Scheer, F; Wiggermann, P | 1 |
Pena, TA; Samavati, L; Soubani, AO | 1 |
Hoshika, Y; Kato, M; Katsura, Y; Kikuchi, K; Misawa, S; Nagaoka, T; Ohashi, R; Seyama, K; Sugawara, T; Takahashi, K; Takekawa, H; Togo, S; Tsuchiya, K; Yoshimi, K | 1 |
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M | 1 |
Malfertheiner, MV; Schreiber, J; Waldburg, N | 1 |
Bignell, EM; Cairns, T; Doyle, S; Kavanagh, K; Larsen, TO; Miggin, SM; O'Hanlon, KA; O'Keeffe, G; Schrettl, M; Stack, D | 1 |
Björkholm, M; Celsing, F; Grane, P; Kalin, M | 1 |
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E | 1 |
Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M | 1 |
Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S | 1 |
Kikuti, K | 1 |
Andersen, CU; Bendstrup, E; Henning, O; Hilberg, O; Lundby, T; Mortensen, J | 1 |
Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M | 1 |
Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L | 1 |
Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W | 1 |
Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y | 1 |
Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G | 1 |
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
Del Rosario, RC; Halloush, RA; Khasawneh, FA | 1 |
Clauss, H; Samuel, R | 1 |
17 review(s) available for voriconazole and Pulmonary Aspergillosis
Article | Year |
---|---|
Management of pulmonary aspergillosis in children: a systematic review.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Aspergillosis; Sensitivity and Specificity; Voriconazole | 2023 |
Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Pulmonary Aspergillosis; Voriconazole | 2023 |
[Anti-infective treatment of fungal infections by Candida and Aspergillus].
Topics: Antifungal Agents; Aspergillus; Candida; Candidemia; Candidiasis, Invasive; Humans; Invasive Fungal Infections; Pulmonary Aspergillosis; Voriconazole | 2023 |
Pulmonary Mycobacterium parascrofulaceum Infection in a Patient with Chronic Progressive Pulmonary Aspergillosis: A Case Report and Literature Review.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Coinfection; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole | 2020 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
Topics: Administration, Oral; Antifungal Agents; Cardiotoxicity; Humans; Itraconazole; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole | 2020 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole | 2021 |
Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature.
Topics: Clinical Decision-Making; Female; Humans; Incidence; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Retrospective Studies; Risk Factors; Tissue Donors; Treatment Outcome; Voriconazole | 2021 |
Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
Topics: Antifungal Agents; Echinocandins; Humans; Itraconazole; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Voriconazole | 2021 |
Graded isavuconazole introduction in a patient with voriconazole allergy.
Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Chemoprevention; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
Topics: Adult; Antifungal Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Dyslipidemias; Gastroesophageal Reflux; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jaundice, Obstructive; Lansoprazole; Liver; Male; Polypharmacy; Proton Pump Inhibitors; Pulmonary Aspergillosis; Simvastatin; Voriconazole | 2016 |
The Current Status of Drug-resistant Aspergillus.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Japan; Mutation; Pulmonary Aspergillosis; Voriconazole | 2016 |
Possible relationship between organizing pneumonia and chronic pulmonary aspergillosis: A case report and literature review.
Topics: Aged; Antifungal Agents; Chronic Disease; Cryptogenic Organizing Pneumonia; Humans; Male; Pneumonectomy; Prednisolone; Pulmonary Aspergillosis; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2017 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole | 2010 |
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole | 2011 |
5 trial(s) available for voriconazole and Pulmonary Aspergillosis
Article | Year |
---|---|
The effects of antifungal therapy on the recurrence of aspergillus infection after pulmonary aspergilloma resection: a study protocol for a single-center, prospective, non-blind, randomized, 24-month, parallel group study.
Topics: Antifungal Agents; Aspergillus; China; Humans; Program Development; Prospective Studies; Pulmonary Aspergillosis; Recurrence; Voriconazole | 2021 |
Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma: A Pilot Randomized Controlled Trial.
Topics: Adult; Female; Hemoptysis; Humans; Lung; Pilot Projects; Pulmonary Aspergillosis; Voriconazole | 2022 |
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2023 |
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2012 |
114 other study(ies) available for voriconazole and Pulmonary Aspergillosis
Article | Year |
---|---|
[Analysis of four cases with congenital pulmonary airway malformation complicated by chronic pulmonary aspergillosis].
Topics: Adolescent; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Child; Female; Humans; Male; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2021 |
Chronic cavitary pulmonary aspergillosis in an infant.
Topics: Antifungal Agents; Female; Humans; Infant; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole | 2021 |
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2022 |
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
Manifestations, Prevalence, Management and Outcome of Invasive
Topics: Antifungal Agents; Aspergillosis; Cross-Sectional Studies; Humans; Liver Transplantation; Mycoses; Prevalence; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2024 |
Positive correlation between voriconazole trough concentrations and C-reactive protein levels in patients with chronic pulmonary aspergillosis: A retrospective cohort study.
Topics: Antifungal Agents; C-Reactive Protein; Creatinine; Humans; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2023 |
Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report.
Topics: Aged; Aged, 80 and over; Escherichia coli; Escherichia coli Infections; Female; Humans; Leukemia, Myeloid, Acute; Pulmonary Aspergillosis; Remission, Spontaneous; Voriconazole | 2023 |
Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2023 |
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
Topics: Animals; Antifungal Agents; COVID-19; Pulmonary Aspergillosis; Retrospective Studies; Triazoles; Voriconazole | 2023 |
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Voriconazole | 2023 |
Feasibility and safety of uniportal thoracoscopy for chronic pulmonary aspergillosis.
Topics: Antifungal Agents; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Aspergillosis; Retrospective Studies; Thoracic Surgery, Video-Assisted; Voriconazole | 2023 |
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Carcinoma, Squamous Cell; Fungemia; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Thyroid Neoplasms; Vancomycin; Voriconazole | 2020 |
COVID-19 associated pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2020 |
Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; United Kingdom; Voriconazole; Weight Loss | 2020 |
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; England; Female; Humans; Incidence; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Risk Assessment; Risk Factors; Skin Neoplasms; Time Factors; Treatment Outcome; Voriconazole; Young Adult | 2020 |
Chronic granulomatous 'Aspergillus lung mass'.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillus; Chest Pain; Granulomatous Disease, Chronic; Hemoptysis; Humans; Image-Guided Biopsy; Incidental Findings; Lung Diseases, Fungal; Male; Pneumonectomy; Postoperative Care; Pulmonary Aspergillosis; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2020 |
Cavernoscopic Views of a Pleural Aspergillosis.
Topics: Antifungal Agents; Aspergillus fumigatus; Humans; Male; Middle Aged; Pleural Diseases; Pulmonary Aspergillosis; Thoracoscopy; Treatment Outcome; Voriconazole | 2021 |
A Neonate With Fungal Lung Nodules Mimicking Pulmonary Malignancy.
Topics: Amphotericin B; Antifungal Agents; Humans; Infant, Newborn; Male; Pulmonary Aspergillosis; Voriconazole | 2020 |
Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.
Topics: A549 Cells; Administration, Inhalation; Animals; Antifungal Agents; Cell Survival; Chitosan; Clathrin; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Lung; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polymers; Pulmonary Aspergillosis; Voriconazole | 2021 |
Lung aspergilloma with pituitary invasive aspergillosis presenting as headache and hyponatraemia.
Topics: Aged; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Endoscopy; Headache; Hemoptysis; Humans; Hypertension; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Magnetic Resonance Imaging; Male; Neuroaspergillosis; Pituitary Diseases; Pulmonary Aspergillosis; Renal Insufficiency, Chronic; Sphenoid Sinusitis; Thoracic Surgery, Video-Assisted; Voriconazole | 2021 |
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; COVID-19; Female; Humans; Immunologic Factors; Incidence; Intensive Care Units; International Cooperation; Male; Outcome and Process Assessment, Health Care; Pulmonary Aspergillosis; Registries; Respiration, Artificial; Risk Factors; SARS-CoV-2; Voriconazole | 2021 |
Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole | 2021 |
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.
Topics: Antifungal Agents; COVID-19; Drug Administration Schedule; Evidence-Based Medicine; Female; Humans; Male; Pulmonary Aspergillosis; Voriconazole | 2021 |
Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Azoles; Chronic Disease; Drug Resistance, Fungal; Fungal Proteins; Humans; Male; Microbial Sensitivity Tests; Mutation; Phenotype; Pulmonary Aspergillosis; Virulence; Voriconazole | 2021 |
Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.
Topics: Antifungal Agents; COVID-19; Humans; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2022 |
A 61-Year-Old Man With Influenza Pneumonia and New Onset Hemoptysis.
Topics: Antifungal Agents; Diagnosis, Differential; Diagnostic Imaging; Fatal Outcome; Hemoptysis; Humans; Influenza, Human; Male; Middle Aged; Pneumonia, Viral; Pulmonary Aspergillosis; Voriconazole | 2021 |
Voriconazole-Induced Periostitis Deformans: A Mimicker of Hypertrophic Pulmonary Osteoarthropathy.
Topics: Adult; Cystic Fibrosis; Humans; Lung Transplantation; Male; Osteoarthropathy, Primary Hypertrophic; Periostitis; Pulmonary Aspergillosis; Voriconazole | 2017 |
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Child; Child, Preschool; Drug Interactions; Female; Floxacillin; Granulomatous Disease, Chronic; Humans; Invasive Fungal Infections; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole; Young Adult | 2017 |
Serum Aspergillus fumigatus-specific IgG antibody decreases after antifungal treatment in chronic pulmonary aspergillosis patients.
Topics: Administration, Oral; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Humans; Immunoglobulin G; Male; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Agranulocytosis associated with voriconazole-induced hypersensitivity syndrome.
Topics: Aged; Agranulocytosis; Antifungal Agents; Drug Hypersensitivity Syndrome; Female; Humans; Meropenem; Pulmonary Aspergillosis; Skin; Voriconazole | 2018 |
Macular toxicity and blind spot enlargement during a treatment by voriconazole: A case report.
Topics: Aged; Antifungal Agents; Electroretinography; Evoked Potentials, Visual; Humans; Macula Lutea; Male; Pulmonary Aspergillosis; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity; Voriconazole | 2018 |
Clinical efficacy of sequential therapy with voriconazole on COPD patients in acute phase with pulmonary aspergillosis and effects on cytokines and pulmonary functions.
Topics: Adult; Aged; Antifungal Agents; Cytokines; Female; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Voriconazole | 2018 |
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Body Weight; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Massive haemoptysis secondary to mycotic pulmonary artery aneurysm in subacute invasive aspergillosis.
Topics: Aneurysm, Infected; Antifungal Agents; Bronchoscopy; Computed Tomography Angiography; Embolization, Therapeutic; Fatal Outcome; Hemoptysis; Humans; Male; Middle Aged; Pneumonia; Pulmonary Aspergillosis; Sepsis; Voriconazole | 2018 |
Painful fingernails in a patient with chronic fibrosing pulmonary aspergillosis.
Topics: Chronic Disease; Dermatitis, Phototoxic; Humans; Male; Middle Aged; Onycholysis; Pain; Photosensitivity Disorders; Pulmonary Aspergillosis; Voriconazole | 2019 |
Aspergillus Sternomyelitis Developed from Chronic Pulmonary Aspergillosis as a Late Complication to Lobectomy for Lung Cancer.
Topics: Aged; Anti-Bacterial Agents; Humans; Lung Diseases, Fungal; Lung Neoplasms; Male; Myelitis, Transverse; Pneumonectomy; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole | 2018 |
[Primary Prophylatic Effect of Voriconazole Against Invasive Infection of Pulmonary Aspergillosis during Remission-Induction Chemotherapy for Acute Myeloid Leukemia].
Topics: Antifungal Agents; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2018 |
Fulminant mulch pneumonitis in a previously healthy child.
Topics: Antifungal Agents; Child; Diagnosis, Differential; Glucocorticoids; Granulomatous Disease, Chronic; Humans; Male; Pneumonia; Pulmonary Aspergillosis; Voriconazole | 2018 |
Twice-Weekly Tacrolimus Can Overcome Pharmacologic Interaction and Help in the Successful Treatment of Pulmonary Aspergillosis in a Liver Transplant Recipient.
Topics: Antifungal Agents; Calcineurin Inhibitors; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Pulmonary Aspergillosis; Tacrolimus; Treatment Outcome; Voriconazole | 2019 |
Large mediastinal mass in a 15-year-old boy.
Topics: Adolescent; Antifungal Agents; Biopsy; Bronchoscopy; Diagnosis, Differential; Humans; Job Syndrome; Male; Mediastinum; Pulmonary Aspergillosis; Radiography, Interventional; Tomography, X-Ray Computed; Voriconazole | 2018 |
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole | 2019 |
Voriconazole-photoinduced polyomavirus-negative Merkel cell carcinoma.
Topics: Antifungal Agents; Biopsy; Carcinoma, Merkel Cell; Churg-Strauss Syndrome; Glucocorticoids; Humans; Male; Merkel cell polyomavirus; Middle Aged; Pulmonary Aspergillosis; Skin; Skin Neoplasms; Sunlight; Time Factors; Voriconazole | 2019 |
Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
Topics: Aged; Antifungal Agents; Follow-Up Studies; Humans; Itraconazole; Maintenance; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2020 |
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2019 |
Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?
Topics: Aged; Anticoagulants; Computed Tomography Angiography; Humans; Male; Pulmonary Artery; Pulmonary Aspergillosis; Pulmonary Circulation; Thrombosis; Voriconazole | 2019 |
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.
Topics: Aged; Antifungal Agents; Humans; Lung; Male; Mycetoma; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Voriconazole-induced periostitis in two post-transplant patients.
Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Voriconazole-induced periostitis in a patient with overlap syndromes.
Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Middle Aged; Periostitis; Pulmonary Aspergillosis; Rheumatic Diseases; Voriconazole | 2014 |
Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host.
Topics: Amphotericin B; Bronchi; Bronchoscopy; Female; Fiber Optic Technology; Humans; Immunocompetence; Larynx; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Trachea; Voriconazole | 2014 |
Aspergilloma and massive haemoptysis.
Topics: Adult; Aneurysm, False; Angiography; Antifungal Agents; Embolization, Therapeutic; Female; Hemoptysis; Humans; Ill-Housed Persons; Mycetoma; Pulmonary Artery; Pulmonary Aspergillosis; Pyrimidines; Severity of Illness Index; Substance Abuse, Intravenous; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
The development of pulmonary aspergillosis and pneumothorax in a patient with neutropenic systemic lupus erythematosus and successful treatment of the first case.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Drainage; Female; Humans; Lupus Erythematosus, Systemic; Neutropenia; Opportunistic Infections; Pneumothorax; Prednisolone; Pulmonary Aspergillosis; Staphylococcal Infections; Staphylococcus aureus; Voriconazole; Young Adult | 2014 |
Rare diagnosis in a neonate who presents with fever.
Topics: Anti-Infective Agents; Antifungal Agents; Biopsy; Diagnosis, Differential; Fever; Granulomatous Disease, Chronic; Humans; Infant, Newborn; Itraconazole; Lung; Male; Pulmonary Aspergillosis; Radiography, Interventional; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2015 |
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction.
Topics: Adult; Aged; Atazanavir Sulfate; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Genotype; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pulmonary Aspergillosis; Pyridines; Ritonavir; Voriconazole | 2014 |
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult | 2015 |
[Mixed types of pulmonary aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2014 |
Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis.
Topics: Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Cytochrome P-450 Enzyme System; Fungal Proteins; Humans; Lung Transplantation; Mutation Rate; Prospective Studies; Pulmonary Aspergillosis; Transplant Recipients; Voriconazole | 2015 |
A 60-year-old asymptomatic woman with pulmonary lesions and cervical lymphadenopathy.
Topics: Antifungal Agents; Antigens, Fungal; Asymptomatic Infections; Comorbidity; Female; Granulomatous Disease, Chronic; Humans; Liver Abscess; Lymph Nodes; Lymphatic Diseases; Membrane Glycoproteins; Middle Aged; Mutation, Missense; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole | 2015 |
Pulmonary Aspergillus Nodule--Still Challenging?
Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole | 2015 |
Recall of provision of sun protection measures to patients with cystic fibrosis being prescribed voriconazole.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Middle Aged; Patient Education as Topic; Pulmonary Aspergillosis; Skin Neoplasms; Sunburn; Sunlight; Voriconazole; Young Adult | 2015 |
Pulmonary aspergillosis presenting with recurrent haemoptysis.
Topics: Antifungal Agents; Aspergillus fumigatus; Cough; Hemoptysis; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Recurrence; Treatment Outcome; Tuberculosis, Pulmonary; Voriconazole | 2015 |
[Excavated persistent pulmonary opacities during a granulomatosis with polyangiitis: think of aspergillosis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Antifungal Agents; Aspergillus fumigatus; Biopsy; Granulomatosis with Polyangiitis; Hemoptysis; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole | 2015 |
Deep-seated mycosis. Aspergillus lentulus.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Humans; Itraconazole; Microscopy, Electron, Scanning Transmission; Pulmonary Aspergillosis; Sputum; Voriconazole | 2015 |
Chronic pulmonary aspergillosis: help is on the way.
Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole | 2016 |
Pleuroscopy With a Bronchoscope.
Topics: Aged; Antifungal Agents; Bronchoscopes; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Thoracoscopy; Treatment Outcome; Voriconazole | 2016 |
Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Bronchoscopy; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Pulmonary Aspergillosis; Tomography Scanners, X-Ray Computed; Voriconazole | 2016 |
Cystic Bronchiectasis Imitating Pulmonary Aspergilloma.
Topics: Aged; Antifungal Agents; Bronchiectasis; Female; Humans; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole | 2016 |
Intrabronchial Voriconazole is a Safe and Effective Measure for Hemoptysis Control in Pulmonary Aspergilloma.
Topics: Adult; Bronchoscopy; Female; Hemoptysis; Humans; Instillation, Drug; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome; Voriconazole | 2017 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2016 |
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole | 2008 |
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2009 |
Aspergillus vertebral osteomyelitis and epidural abscess.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2009 |
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole | 2009 |
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
Topics: Anticonvulsants; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Phenytoin; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
[Porphyria cutanea tarda revealed by voriconazole].
Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole | 2010 |
Antifungal management.
Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Aspergillus niger; Female; Humans; Lung; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole | 2010 |
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Case report 2: Fungal infections in chronic obstructive pulmonary disease.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Belgium; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography, Thoracic; Steroids; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis in a non-neutropenic critical patient.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole | 2011 |
Management of voriconazole hepatotoxicity in a lung transplant patient.
Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Fatal outcome of invasive tracheal aspergillosis].
Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult | 2011 |
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).
Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Paraproteinemias; Pulmonary Aspergillosis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2011 |
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
[Intralobar pulmonary sequestration with aspergillosis in an asymptomatic 39-year-old man].
Topics: Adult; Bronchopulmonary Sequestration; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Radiography; Thoracotomy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus.
Topics: Animals; Animals, Outbred Strains; Antifungal Agents; Aspergillus fumigatus; Cell Line; Fungal Proteins; Gene Deletion; Macrophages; Mice; Moths; Peptide Synthases; Phenotype; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Virulence; Voriconazole | 2011 |
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Voriconazole-induced QT interval prolongation and torsades de pointes.
Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole | 2011 |
[Pulmonary aspergillosis and HIV infection: about two cases].
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole | 2012 |
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole | 2012 |
[Photo quiz: Deep-seated mycosis].
Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Pyrimidines; RNA, Fungal; Scedosporium; Sputum; Triazoles; Voriconazole | 2012 |
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Aged; Antifungal Agents; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole | 2012 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
Topics: Antifungal Agents; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Colectomy; Fever; Humans; Intensive Care Units; Intestinal Diseases; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Simultaneous mold infections in an orthotopic heart transplant recipient.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole | 2008 |